$3250 | Single User
$4650 | Site License
$5650 | Global License

Hemophilia Market, By Types (Hemophilia A, Hemophilia B, and Hemophilia C), By Treatment (On-demand and Prophylaxis), By Therapy and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jul 2020 | 270562 | In Stock
Related Topics: COVID , Pfizer

Introduction

REPORT HIGHLIGHT

The hemophilia market is estimated to represent a global market of USD 11.62 billion by 2019 with growth rate of 5.3%.

Market Dynamics

Over the eight years to 2016, revenue for the hemophilia industry is anticipated trend higher. Increasing neonatal population is expected to drive the hemophilia diagnosis demand globally. The World Population Meter stated that more than 88.0 billion newborns were reported in 2015 resulting in about 250 births per minute. Of which, approximately 2.8 million infants died within the first month, due to lack of skilled care and proper screening of the babies. The World Health Organization (WHO) also stated that around 2.6 million children died in their first month of life across the globe, which is 7,000 newborn deaths every day. In addition, strong product pipeline will further stimulate the industry growth to great extent over the future period. For example, N9-GP, Concizumab, N8-GP, and Recombinant factor VIIa are some of the bleeding disorder therapeutics under clinical investigations by Novo Nordisk. Despite the industry pipeline increasing, some potential threats exist which will likely to hinder growth prospects going forward. Factors such as high treatment cost coupled with low acceptance of advanced technologies are posing a potential threat to the market.

Types Takeaway

In terms of types, the market is categorized into A, B, C, and other types. Type A accounted for the highest share of the total market. In 2019, the segment recorded 6.8 billion and is expected to dominate the global market over the forecast period. This type is acquired due to the deficiency of clotting factor VIII, which is an anti-hemophilic factor (AHF). According to the National Hemophilia Foundation (NHF), 1 in 5,000 male population affect with type A disorder, which makes it four times more common compared to the type B. As per the Hemophilia News Today, around 4,000 to 5,000 males are affected with type A disease worldwide. Markets besides hemophilia A, B & C is expected to generate the remaining 5.0% of market revenue in 2019.

COVID 19 Impact on hemophilia market

As key companies move from reacting to mitigating the impact of the COVID-19 outbreak, they are keenly focusing on strategies that may result in emerging as strong market player. The published research included the detailed study related to the COVID-19 impact on the supply chain based on both downstream and upstream markets. The proposed report also includes the future development in the hemophilia Market in relation with the impact of COVID-19 on the market.

Key Vendor Takeaway

Companies namely, Novo Nordisk, Bayer AG, Pfizer, Inc., Baxalta, and Biogen are profiled. In light of more players entering in this market. the degree of competition has intensified over a couple of years. Competition is based on the development of new therapeutics and co-pay programs.

For example, Grifols provide co-pay programs such as ALPHANATE Copay Program and AlphaNine SD Copay card for this bleeding disorder treatment with an unlimited monetary limit. In addition, companies are engaged in donation activities with government organizations. For instance, in 2016, the World Federation of Hemophilia collected 1.5 million units of anti-hemophilic agents from CSL Behring as a donation on World Hemophilia Day.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018

Base Year – 2019

Estimated Year – 2020

Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

HEMOPHILIA MARKET, BY TYPES

Hemophilia A

Hemophilia B

Hemophilia C

Others

HEMOPHILIA MARKET, BY TREATMENT

On-demand

Prophylaxis

HEMOPHILIA MARKET, BY THERAPY

Immune Tolerance Induction (ITI) therapy

Replacement therapy

Gene therapy

HEMOPHILIA MARKET, BY REGION

North America

U.S.

Canada

Europe

Germany

France

Rest of Europe

Asia Pacific

India

China

Rest of APAC

Rest of the World

Middle East and Africa

Latin America

Table of Contents
for Hemophilia Market, By Types (Hemophilia A, Hemophilia B, and Hemophilia C), By Treatment (On-demand and Prophylaxis), By Therapy and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

  • TABLE OF CONTENT

    1. HEMOPHILIA MARKET OVERVIEW

    1.1. Study Scope

    1.2. Assumption and Methodology

    2. EXECUTIVE SUMMARY

    2.1. Key Market Facts

    2.2. Geographical Scenario

    2.3. Companies in the Market

    3. HEMOPHILIA KEY MARKET TRENDS

    3.1. Market Drivers

    3.1.1. Impact Analysis of Market Drivers

    3.2. Market Restraints

    3.2.1. Impact Analysis of Market Restraints

    3.3. Market Opportunities

    3.4. Market Future Trends

    4. HEMOPHILIA INDUSTRY STUDY

    4.1. Porter’s Analysis

    4.2. Market Attractiveness Analysis

    4.3. Regulatory Framework Analysis

    4.4 HEMOPHILIA MARKET: COVID-19 IMPACT ANALYSIS

    4.4.1 Pre-COVID-19 Impact Analysis

    4.4.2 Post-COVID-19 Impact Analysis

    4.4.3 Top Performing Segments

    4.4.4 Marginal Growth Segments

    4.4.5 Top Looser Segments

    4.4.6 Marginal Loss Segments

    5. HEMOPHILIA MARKET LANDSCAPE

    5.1. Market Share Analysis

    6. HEMOPHILIA MARKET – BY TYPES

    6.1. Overview

    6.2. Hemophilia A

    6.2.1. Overview

    6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.3. Hemophilia B

    6.3.1. Overview

    6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.4. Hemophilia C

    6.4.1. Overview

    6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.5. Others

    6.5.1. Overview

    6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7. HEMOPHILIA MARKET – BY TREATMENT

    7.1. Overview

    7.2. On-demand

    7.2.1. Overview

    7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.3. Prophylaxis

    7.3.1. Overview

    7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    8. HEMOPHILIA MARKET – BY THERAPY

    8.1. Overview

    8.2. Immune Tolerance Induction (ITI) therapy

    8.2.1. Overview

    8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    8.3. Replacement therapy

    8.3.1. Overview

    8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    8.4. Gene therapy

    8.4.1. Overview

    8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9. HEMOPHILIA MARKET– BY GEOGRAPHY

    9.1. Introduction

    9.2. North America

    9.2.1. Overview

    9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.2.3. U.S.

    9.2.3.1. Overview

    9.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.2.4. Canada

    9.2.4.1. Overview

    9.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.3. Europe

    9.3.1. Overview

    9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.3.3. France

    9.3.3.1. Overview

    9.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.3.4. Germany

    9.3.4.1. Overview

    9.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.3.5. Rest of Europe

    9.3.5.1. Overview

    9.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.4. Asia Pacific (APAC)

    9.4.1. Overview

    9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.4.3. China

    9.4.3.1. Overview

    9.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.4.4. India

    9.4.4.1. Overview

    9.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.4.5. Rest of APAC

    9.4.5.1. Overview

    9.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.5. Rest of the World

    9.5.1. Overview

    9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.5.3. Latin America

    9.5.3.1. Overview

    9.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.5.4. Middle East and Africa

    9.5.4.1. Overview

    9.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    10. KEY VENDOR ANALYSIS

    10.1. Novo Nordisk

    10.1.1. Company Overview

    10.1.2. SWOT Analysis

    10.1.3. Key Developments

    10.2. Bayer AG

    10.2.1. Company Overview

    10.2.2. SWOT Analysis

    10.2.3. Key Developments

    10.3. Pfizer, Inc.

    10.3.1. Company Overview

    10.3.2. SWOT Analysis

    10.3.3. Key Developments

    10.4. Baxalta

    10.4.1. Company Overview

    10.4.2. SWOT Analysis

    10.4.3. Key Developments

    10.5. Biogen

    10.5.1. Company Overview

    10.5.2. SWOT Analysis

    10.5.3. Key Developments

    *Client can request additional company profiling as per specific requirements

    11. 360 DEGREE ANALYSTVIEW

    12. APPENDIX

    12.1. Research Methodology

    12.2. Abbreviations

    12.3. Disclaimer

    12.4. Contact Us

List Of Tables
in Hemophilia Market, By Types (Hemophilia A, Hemophilia B, and Hemophilia C), By Treatment (On-demand and Prophylaxis), By Therapy and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Tables

Table 1 List of Acronyms

Table 2 Key Market Facts, 2016 – 2027

Table 3 Market Drivers: Impact Analysis

Table 4 Market Restraint: Impact Analysis

Table 5 Market Opportunity: Impact Analysis

Table 6 PEST Analysis

Table 7 Porter’s Five Forces Analysis

Table 8 Company Market Share Analysis

Table 9 Global Hemophilia Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)

Table 10 Hemophilia Market, by Types, 2016 – 2027 (USD Billion)

Table 11 Hemophilia Market, by Treatment, 2016 – 2027 (USD Billion)

Table 12 Hemophilia Market, by Therapy, 2016 – 2027 (USD Billion)

Table 13 Hemophilia Market, by Geography, 2016 – 2027 (USD Billion)

Table 14 North America Hemophilia Market, 2016 – 2027 (USD Billion)

Table 15 U.S. Hemophilia Market, 2016 – 2027 (USD Billion)

Table 16 Canada Hemophilia Market, 2016 – 2027 (USD Billion)

Table 17 Europe Hemophilia Market, 2016 – 2027 (USD Billion)

Table 18 France Hemophilia Market, 2016 – 2027 (USD Billion)

Table 19 Germany Hemophilia Market, 2016 – 2027 (USD Billion)

Table 20 Asia Pacific Hemophilia Market, 2016 – 2027 (USD Billion)

Table 21 China Hemophilia Market, 2016 – 2027 (USD Billion)

Table 22 India Hemophilia Market, 2016 – 2027 (USD Billion)

Table 23 Latin America Hemophilia Market, 2016 – 2027 (USD Billion)

Table 24 MEA Hemophilia Market, 2016 – 2027 (USD Billion)

List Of Figures, Charts and Diagrams
in Hemophilia Market, By Types (Hemophilia A, Hemophilia B, and Hemophilia C), By Treatment (On-demand and Prophylaxis), By Therapy and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Figures

Figure 1 Research Methodology

Figure 2 Research Process Flow Chart

Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)

Figure 4 Regulatory Framework Analysis

Figure 5 Hemophilia Market, by Types, 2016 – 2027 (USD Billion)

Figure 6 Hemophilia Market, by Treatment, 2016 – 2027 (USD Billion)

Figure 7 Hemophilia Market, by Therapy, 2016 – 2027 (USD Billion)

Figure 8 Hemophilia Market, by Geography, 2016 – 2027 (USD Billion)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270562 | AV180

Number of Pages

238

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Hemophilia A - Pipeline Review, H2 2016
Hemophilia A - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutical and Heal...
23 Nov 2016 by Global Markets Direct USD $2,000 More Info
Global Hemophilia Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatm...
01 Nov 2016 by GBI Research USD $4,995 More Info
Global Hemophilia Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Hemophilia A and B Recombinant Factor Replacement Therapy - US Drug Forecast and Market Analysis to 2024
Hemophilia A and B Recombinant Factor Replacement Therapy - US Drug Forecast and Market Analysis to ...
11 Dec 2015 by Global Data USD $4,995 More Info
Hemophilia A and B Recombinant Factor Replacement Therapy - Japan Drug Forecast and Market Analysis to 2024
Hemophilia A and B Recombinant Factor Replacement Therapy - Japan Drug Forecast and Market Analysis ...
11 Dec 2015 by Global Data USD $4,995 More Info
Hemophilia A and B Recombinant Factor Replacement Therapy - Argentina Drug Forecast and Market Analysis to 2024
Hemophilia A and B Recombinant Factor Replacement Therapy - Argentina Drug Forecast and Market Analy...
11 Dec 2015 by Global Data USD $4,995 More Info
Hemophilia A and B Recombinant Factor Replacement Therapy - 5EU Drug Forecast and Market Analysis to 2024
Hemophilia A and B Recombinant Factor Replacement Therapy - 5EU Drug Forecast and Market Analysis to...
11 Dec 2015 by Global Data USD $6,995 More Info
Hemophilia A and B Recombinant Factor Replacement Therapy - Current and Future Players
Hemophilia A and B Recombinant Factor Replacement Therapy - Current and Future PlayersSummaryGlobalD...
11 Dec 2015 by Global Data USD $2,995 More Info
Hemophilia A and B Recombinant Factor Replacement Therapy - US Drug Forecast and Market Analysis to 2024
Hemophilia A and B Recombinant Factor Replacement Therapy - US Drug Forecast and Market Analysis to ...
11 Dec 2015 by Global Data USD $4,995 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Hemophilia Market, By Types (Hemophilia A, Hemophilia B, and Hemophilia C), By Treatment (On-demand and Prophylaxis), By Therapy and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...